● Recruiting

An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

Condition: GERD (Gastroesophageal Reflux Disease) · Sponsor: HK inno.N Corporation

PhaseN/A

Planned participants5384

Who can joinAll sexes, 19 Years to no upper limit

Healthy volunteersNo

About this study

This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.

This description comes directly from the study's public registry record.

Talk to the study team

yong an jeong · 82-31-5176-4673 · yongan.jeong@inno-n.com

seung gye cho · 82-31-5176-4676 · seungkye.cho@inno-n.com

Always discuss trial participation with your own doctor first.

Locations (1)

HK inno.N

Seoul, South Korea

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07678177